Searching for a 'Mujra' Weight Loss Injection? Here's What You Need to Know

The biggest misconception: 'Mujra' is a different product

It isn't. There is no weight-loss injection called mujra. The name is a phonetic near-miss for Mounjaro, which is easy to misread or mishear, particularly if you first encountered it in conversation, on social media, or via voice search. Some people also arrive here after seeing 'Mounjaro' written down and misreading it at speed.

That's a straightforward thing to clear up, and there's no embarrassment in it. Weight-loss medicines have unusual brand names that don't follow any obvious English pronunciation rule. Mounjaro is pronounced "mown-JAR-oh", and once you know that, the spelling sticks.

What matters more is what the medicine actually is. Mounjaro contains tirzepatide, manufactured by Eli Lilly. It's a once-weekly subcutaneous injection delivered via a pre-filled KwikPen. You inject it yourself, at home, into the abdomen, thigh, or upper arm, rotating the site each week. The pen contains four weekly doses, so one pen lasts a month. If you want an overview of how weight-loss injections are used more broadly in the UK, that page covers the practical picture across the licensed medicines.

How tirzepatide works, and why its mechanism is unusual

Most GLP-1 medicines work on a single receptor. Tirzepatide activates two: the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. Both are gut hormones involved in appetite regulation and blood-sugar balance. Activating them together slows the rate at which food leaves your stomach, increases the feeling of fullness after meals, and reduces overall caloric intake over time.

The clinical evidence is substantial. SURMOUNT-1, a 72-week trial involving 2,539 adults with obesity, found average weight reductions of around 20–21% at the 15mg dose, results reported in the New England Journal of Medicine. These figures come from a controlled trial setting and are not a guarantee of what any individual will experience, but they established tirzepatide's standing as one of the most effective medicines of this class assessed to date.

Treatment starts at 2.5mg. The starting dose exists to let your system adjust, not to produce weight loss straight away. Your prescriber manages the titration schedule from there. If you're curious about the Mounjaro injection for weight loss in more detail, including how the dose steps work, that page goes further.

Who is assessed as eligible, and what the process involves

The licensed criteria for tirzepatide in the UK cover adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A BMI figure alone doesn't determine the outcome, the prescriber reviews your full medical history, current medicines, and any contraindications before making a clinical decision.

Tirzepatide is a Black Triangle (▼) medicine, meaning the MHRA requires additional monitoring while post-market data accumulates. The NHS tirzepatide page sets out the side-effect profile and what to watch for, including common gastrointestinal symptoms like nausea, diarrhoea, and constipation, which tend to be most noticeable at dose increases and often settle within a week or two.

Pregnancy, breastfeeding, and trying to conceive are all situations where tirzepatide is not recommended. It is also not licensed for anyone under 18. Women taking oral contraceptives should be aware that absorption may be reduced during the first four weeks of treatment and for four weeks after each dose increase; a non-oral method of contraception should be added during those windows. The NHS England weight management injections guidance covers contraception and HRT considerations in full.

Getting a legitimate prescription in the UK

Tirzepatide is a prescription-only medicine. The only legal route to it is a consultation with a qualified prescriber who assesses your suitability and issues a prescription through a registered pharmacy. There is no shortcut, and the MHRA has been clear that the rise in online sellers offering weight loss injections without a clinical assessment poses real safety risks, including counterfeit pens seized in large quantities across the UK.

Before using any online pharmacy, check it on the GPhC register. A GPhC premises number is a verifiable fact, not a badge anyone can self-apply. If a seller can't provide one, that's a reliable red flag. It's also worth understanding what low prices for weight-loss injections sometimes signal before making a decision based on cost alone.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber. If you're ready to find out whether tirzepatide is appropriate for your situation, you can explore the full range of weight-loss treatments we offer and check your eligibility through a free consultation. There's no obligation, and the clinical review happens the same day.

For context on what private treatment costs and what a transparent price should include, the weight-loss treatment overview covers that honestly. And if you have questions before starting, our FAQs address the most common ones our prescribers hear, including details on how a weight loss injection r egimen is typically structured and what to expect across the first three weight loss injections as your body adjusts to treatment.